| Salusin-alpha - a New Factor in the Pathogenesis of Lipid Abnormalities in Hemodialysis Patients (NCT01448174) | Poznan University of Medical Sciences | 2011-10-01 |
| ACCU-CHEK® Aviva Expert Study: Does Use of a Bolus Advisor Improve Glycemic Control in Patients Not Achieving Optimal Control Using Multiple Daily Injections (MDI)? (NCT01460446) | Hoffmann-La Roche | 2011-10-01 |
| A Study of the Effect of Dulaglutide on How the Body Handles Oral Contraceptive in Healthy Female Participants (NCT01458210) | Eli Lilly and Company | 2011-10-01 |
| A Study on the Effects of LY2409021 on the Electrical Impulses of the Heart (NCT01460368) | Eli Lilly and Company | 2011-10-01 |
| Safety, Tolerability and Pharmacokinetics of Liraglutide-depot in Healthy Subjects (NCT01473953) | Novo Nordisk A/S | 2011-10-01 |
| A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 2 Diabetes (NCT01467414) | Novo Nordisk A/S | 2011-10-01 |
| Effects of Different Early Intensive Therapies on Long-term β-cell Function (NCT01471808) | Sun Yat-sen University | 2011-10-01 |
| Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin (NCT01388361) | Novo Nordisk A/S | 2011-09-01 |
| Comparison of Biphasic Insulin Aspart 30 Individually Adjusted by the Subject and the Trial Physician, Both Combined With Metformin in Subjects With Type 2 Diabetes (NCT01427920) | Novo Nordisk A/S | 2011-09-01 |
| A Study Of Three PF-05190457 Formulations In Healthy Volunteers (NCT01522807) | Pfizer | 2011-09-01 |
| A Study in Patients With Type 2 Diabetes (NCT01408095) | Eli Lilly and Company | 2011-09-01 |
| Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gastroparesis (NCT01452815) | Tranzyme, Inc. | 2011-09-01 |
| The Effect of GLP-1 Receptor Activation on Central Reward and Satiety in Obesity and Diabetes (NCT01281228) | Amsterdam UMC, location VUmc | 2011-09-01 |
| Mulberry Leaf Extract and Blood Glucose Control in Diabetics (NCT01305434) | Craig, Nancy, M.D. | 2011-09-01 |
| A Study in Adults With Type 2 Diabetes (NCT01421459) | Eli Lilly and Company | 2011-09-01 |
| A Study of the Effect of Dulaglutide on the Action of Warfarin in Healthy Participants (NCT01432938) | Eli Lilly and Company | 2011-09-01 |
| A Study of the Effect of Dulaglutide on How Body Handles Digoxin in Healthy Participants (NCT01436201) | Eli Lilly and Company | 2011-09-01 |
| Non-Interventional Study on Safety of Liraglutide in Subjects With Type 2 Diabetes (NCT01345734) | Novo Nordisk A/S | 2011-09-01 |
| Trial Investigating the Safety of NNC 0113-0987 in Healthy Male Subjects (NCT01405261) | Novo Nordisk A/S | 2011-08-01 |
| A Study of LY2189265 and Sitagliptin in Participants With Type 2 Diabetes (NCT01408888) | Eli Lilly and Company | 2011-08-01 |
| Observational, Safety Study of NovoNorm® (Repaglinide) and Insulin Analogue Combination Therapy in Type 2 Diabetes in Korea (NCT01355718) | Novo Nordisk A/S | 2011-08-01 |
| Efficacy and Safety of TAK-875 in Combination With Sitagliptin in Participants With Type 2 Diabetes Mellitus (NCT01414920) | Takeda | 2011-08-01 |
| Efficacy and Safety of Empagliflozin (BI 10773) / Linagliptin (BI 1356) Fixed Dose Combination in Treatment naïve and Metformin Treated Type 2 Diabetes Patients (NCT01422876) | Boehringer Ingelheim | 2011-08-01 |
| A Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Alone or in Combination With a Sulphonylurea (NCT01381900) | Janssen Research & Development, LLC | 2011-08-01 |
| Oxidative Stress Markers Evaluation Before and After Periodontal Treatment of Diabetics Type 2 Patients (NCT01475435) | University of Sao Paulo | 2011-08-01 |
| A Pharmacodynamic/Pharmacokinetic Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus on Treatment With Lisinopril (NCT01398267) | Hoffmann-La Roche | 2011-08-01 |
| Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND) (NCT01394952) | Eli Lilly and Company | 2011-07-22 |
| Evaluating the Safety and Effectiveness of Liraglutide in Subjects With Type 2 Diabetes (NCT01403025) | Novo Nordisk A/S | 2011-07-19 |
| A Study of GSK256073 in Subjects With Type 2 Diabetes Mellitus Who Are Being Treated With Metformin (NCT01376323) | GlaxoSmithKline | 2011-07-13 |
| Albiglutide Thorough ECG Study in Healthy Volunteers (NCT01406262) | GlaxoSmithKline | 2011-07-06 |
| Safety and Tolerability of Ascending Intravenous Doses of PF-05231023 In Adult Subjects With Type 2 Diabetes (NCT01396187) | Pfizer | 2011-07-01 |
| A Study To Evaluate PF-05175157 In Healthy Volunteers (NCT01433380) | Pfizer | 2011-07-01 |
| Comprehensive Postpartum Screening Strategies for Women With Gestational Diabetes Mellitus (GDM) (NCT00849849) | Woman's | 2011-07-01 |
| A Study Of PF-05190457 In Healthy Volunteers And Type-2 Diabetic Patients (NCT01372163) | Pfizer | 2011-07-01 |
| An Efficacy, Safety, and Tolerability Study of Canagliflozin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy (NCT01340664) | Janssen Research & Development, LLC | 2011-07-01 |
| The Role Of Nitazoxanide, Interferon Alfa And Ribavirin In Treatment Of Hepatitis C Infected Type 2 Diabetic Patients (NCT01770483) | Services Institute of Medical Sciences, Pakistan | 2011-07-01 |
| Pharmacokinetics/Pharmacodynamics of Albiglutide (NCT01357889) | GlaxoSmithKline | 2011-07-01 |
| A Study of PF-05175157 in Healthy Volunteers and Type 2 Diabetic Patients (NCT01396161) | Pfizer | 2011-07-01 |
| An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes (NCT01400971) | Eli Lilly and Company | 2011-07-01 |
| Impact of a Multidisciplinary Therapeutic Education Program Being Set up for Patients With Type 2 Diabetes Mellitus (NCT03192228) | Groupe Hospitalier Pitie-Salpetriere | 2011-07-01 |
| Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes (NCT01351675) | Biogen | 2011-06-30 |
| First Time in Human Study Using GSK2330672 (NCT01416324) | GlaxoSmithKline | 2011-06-15 |
| A Study in Healthy Male Volunteers to Investigate Different Doses of a New Drug for the Treatment of Metabolic Diseases (NCT01340911) | Sirtris, a GSK Company | 2011-06-03 |
| Continuous Glucose Monitoring Self-Monitored Blood Glucose Type 2 Therapy Matrix Definition (NCT01390610) | HealthPartners Institute | 2011-06-01 |
| Comparison of the Bioavailability of Metformin Between Medium Dose Linagliptin/Metformin Tablets and Medium Dose Glucophage Tablet Given With Linagliptin Tablet (NCT01383356) | Boehringer Ingelheim | 2011-06-01 |
| 12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes Mellitus (NCT01370005) | Boehringer Ingelheim | 2011-06-01 |
| A Trial to Investigate Efficacy and Usability of Published Best Practice to Control Glycaemia (NCT01407289) | Medical University of Graz | 2011-06-01 |
| A 3-fold Crossover Bioequivalence Study Between Glucobay Orally Disintegrating Tablet (ODT) and Glucobay Standard Tablet (NCT01388153) | Bayer | 2011-06-01 |
| INV-144 Versus Losartan in Hypertension and Type 2 Diabetes Mellitus Patients With Macroalbuminuria (NCT01398423) | InVasc Therapeutics, Inc. | 2011-06-01 |
| Study of Safety and Efficacy of PF-04991532 in Subjects With Type 2 Diabetes (NCT01338870) | Pfizer | 2011-06-01 |
| Vildagliptin Versus Sitagliptin - Differences in Fasting Plasma Glucose Lowering Efficacy (NCT01398592) | Novartis Pharmaceuticals | 2011-06-01 |
| Comparison of Two Insulin Degludec Formulations in Subjects With Type 2 Diabetes Mellitus (NCT01364428) | Novo Nordisk A/S | 2011-06-01 |
| A Comparison of Two Initial Dosing Formulas (NCT01377155) | Diabetes Care Center | 2011-06-01 |
| A Study to Evaluate the Effect of JNJ-28431754 (Canagliflozin) on Post-Meal Glucose in Patients With Type 2 Diabetes Mellitus (NCT01381887) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2011-06-01 |
| Glucophage XR® Observational Study (NCT01336673) | Merck KGaA, Darmstadt, Germany | 2011-06-01 |
| Efficacy and Safety of Insulin Degludec/Insulin Aspart in Insulin-naïve Subjects With Type 2 Diabetes Using Two Dosing Regimens (NCT01365507) | Novo Nordisk A/S | 2011-06-01 |
| A Single Dose Study In Japanese And Western Healthy Subjects To Investigate The Safety, Tolerability And Pharmacokinetics Of PF-04991532 (NCT01369277) | Pfizer | 2011-06-01 |
| A Study of LY2881835 in Healthy People and People With Diabetes (NCT01358981) | Eli Lilly and Company | 2011-05-24 |
| Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes (NCT01336023) | Novo Nordisk A/S | 2011-05-23 |
| Mobile Sipoo - Telemonitoring With Combined With Active Assistance Technology (NCT01547156) | VTT Technical Research Centre of Finland | 2011-05-01 |
| Self-monitoring of Blood Glucose in Insulin-treated Patients With Type 2 Diabetes (NCT01460459) | Medical Research Foundation, The Netherlands | 2011-05-01 |
| Empagliflozin (BI 10773) Comprehensive add-on Study in Japanese Subjects With Type 2 Diabetes Mellitus (NCT01368081) | Boehringer Ingelheim | 2011-05-01 |
| Calorie Reduction Or Surgery: Seeking Remission for Obesity And Diabetes (NCT01295229) | University of Washington | 2011-05-01 |
| Behavioral Family Systems Therapy for Teens With Type 2 Diabetes (NCT05422807) | Nemours Children's Clinic | 2011-04-01 |
| Behavioral Family Systems Therapy (BFST) for Teens With Type 2 Diabetes (NCT03159221) | Nemours Children's Clinic | 2011-04-01 |
| Finding a Safe and Effective Dose of Linagliptin in Pediatric Patients With Type 2 Diabetes (NCT01342484) | Boehringer Ingelheim | 2011-04-01 |
| A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in India (NCT01351922) | Novo Nordisk A/S | 2011-04-01 |
| A Study of RO6807952 in Patients With Diabetes Mellitus Type 2 (NCT01358929) | Hoffmann-La Roche | 2011-04-01 |
| Comparison of the Efficacy and Safety of Two Insulin Intensification Strategies (NCT01175824) | Eli Lilly and Company | 2011-04-01 |
| TRANSforming InTerprofessional Cardiovascular Prevention in Primary Care (NCT01418716) | Fonds de la Recherche en Santé du Québec | 2011-04-01 |
| Sport as Therapy: a 6-months Lifestyle-Intervention for Patients With Coronary Artery Disease and/or Diabetes (NCT03208751) | Technical University of Munich | 2011-04-01 |
| Effects of Caloric Restriction Alone Versus Postoperative Caloric Restriction Following Bariatric Surgery on Glucose Metabolism in Patients With Diabetes Mellitus (NCT01083108) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2011-03-31 |
| Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403) (NCT01296412) | Merck Sharp & Dohme LLC | 2011-03-11 |
| Evaluation of a 4mmx32G Pen Needle for Injection of Basal Insulin Doses Above 40 Units (NCT01334606) | Becton, Dickinson and Company | 2011-03-01 |
| Comparing the Efficacy and Safety of NN1250 Once Daily When Titrated Using 2 Different Algorithms in Insulin naïve Subjects With Type 2 Diabetes Mellitus (NCT01326026) | Novo Nordisk A/S | 2011-03-01 |
| Exercise Consultation for Type 2 Diabetes Patients in Real Life (NCT01264809) | University Hospital Center of Martinique | 2011-03-01 |
| Complementary and Integrative Therapy for Diabetic Neuropathy (NCT01296308) | Universität Duisburg-Essen | 2011-03-01 |
| Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Empagliflozin in Chinese Female and Male Patients With Type 2 Diabetes Mellitus (NCT01316341) | Boehringer Ingelheim | 2011-03-01 |
| Effect of Oral Contraceptives After Administration of Semaglutide in Subjects With Type 2 Diabetes (NCT01324505) | Novo Nordisk A/S | 2011-03-01 |
| Comparison of Two Biphasic Insulin Aspart 30 Treatment Regimens in Subjects With Type 2 Diabetes Not Achieving HbA1c Treatment Targets on OADs Alone (NCT01215435) | Novo Nordisk A/S | 2011-03-01 |
| Single-Dose And Multiple-Dose Safety And Tolerability Study Of PF-04856883 In Type 2 Diabetic Adult Females (NCT01301456) | Pfizer | 2011-03-01 |
| Life-long Tele-monitoring of Patients With Type 2 Diabetes Mellitus in Central Greece (NCT01498367) | Regional Health Authority of Sterea & Thessaly | 2011-03-01 |
| A Study of the Effect of LY2189265 on Two Blood Pressure Drugs (NCT01324388) | Eli Lilly and Company | 2011-03-01 |
| Optimizing the Beneficial Health Effects of Exercise for Diabetes: Focus on the Liver! (NCT01317576) | Bram Brouwers | 2011-03-01 |
| Rate of Change of HbA1c (dx/dt) May Predict Progression to Type 2 DM (NCT01315808) | Wyckoff Heights Medical Center | 2011-03-01 |
| Observational Study on Effectiveness and Safety of Liraglutide in Subjects With Type 2 Diabetes (NCT01288326) | Novo Nordisk A/S | 2011-02-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 135585 XX in Patients With Type 2 Diabetes (NCT01282970) | Boehringer Ingelheim | 2011-02-01 |
| Effects of Alogliptin on Pancreatic Beta Cell Function (NCT01303055) | Aichi Gakuin University | 2011-02-01 |
| Safety And Tolerability Of Escalating Intravenous Doses Of PF-05231023 In Adult Subjects With Type 2 Diabetes (NCT01285518) | Pfizer | 2011-02-01 |
| Safety and Efficacy of Empagliflozin (BI 10773) and Sitagliptin Versus Placebo Over 76 Weeks in Patients With Type 2 Diabetes (NCT01289990) | Boehringer Ingelheim | 2011-02-01 |
| Multiple Dose Study Of PF-04937319 In Patients With Type 2 Diabetes (NCT01272804) | Pfizer | 2011-02-01 |
| Study of the Potential of a Macronutrient Balanced Normocaloric Diet to Treat Lifestyle Diseases (NCT01278121) | Norwegian University of Science and Technology | 2011-02-01 |
| Effect of LY2189265 on Insulin Secretion in Response to Intravenous Glucose (NCT01300260) | Eli Lilly and Company | 2011-02-01 |
| Diet, Insulin Sensitivity And the Brain (NCT01297738) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2011-02-01 |
| Efficacy of Ubiquinone and Combined Antioxidant Therapy in Non-proliferative Diabetic Retinopathy (NCT02062034) | University of Guadalajara | 2011-02-01 |
| Effectiveness of Two Interventions in Patients With Low Educational Level With Diabetes to Reduce Inequalities in Self-care Behavior (NCT01849731) | Andalusian School of Public Health | 2011-02-01 |
| A Randomized, Double-Blind, Comparator- and Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602 in Type 2 Diabetic Patients (NCT01280695) | Metabolic Solutions Development Company | 2011-02-01 |
| Safety and Efficacy of BI 10773 as add-on to Insulin Regimen in Patients With Type 2 Diabetes Mellitus (NCT01306214) | Boehringer Ingelheim | 2011-02-01 |
| Efficacy of Insulin Lispro Mix 50/50 Therapy (NCT01303042) | Aichi Gakuin University | 2011-02-01 |
| A Study Comparing Insulin Intensification Therapies in Patients With Type 2 Diabetes Mellitus (NCT01175811) | Eli Lilly and Company | 2011-02-01 |